<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="Tab1">
 <label>Table 1</label>
 <caption>
  <p>Shows the prevention strategies that have been developed to protect against sexually transmitted infections and their effectiveness</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th>Sexually Transmitted Infection</th>
    <th>Prevention strategies*</th>
    <th>Effectiveness</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td rowspan="3">Non-viral infections (Chlamydia trachomatis/Neisseria gonorrhoea/Trichomonas vaginalis/Mycoplasma genitalium/Ureaplasma urealyticum/Treponema pallidum)</td>
    <td>•Condoms</td>
    <td>•90% effective with perfect use [
     <xref ref-type="bibr" rid="CR10">10</xref>]
    </td>
   </tr>
   <tr>
    <td>•Testing for STIs and treating when necessary</td>
    <td>•100% effective unless there is poor adherence to treatment, reinfection or drug resistance</td>
   </tr>
   <tr>
    <td>•Partner notification</td>
    <td>•Reducing onward transmission, reinfection and the cost to make an STI diagnosis [
     <xref ref-type="bibr" rid="CR11">11</xref>]
    </td>
   </tr>
   <tr>
    <td rowspan="3">Human papilloma virus (HPV)</td>
    <td>•Condoms</td>
    <td>•Up to 50% [
     <xref ref-type="bibr" rid="CR12">12</xref>]
    </td>
   </tr>
   <tr>
    <td>•Circumcision</td>
    <td>•50% [
     <xref ref-type="bibr" rid="CR13">13</xref>]
    </td>
   </tr>
   <tr>
    <td>•HPV vaccination</td>
    <td>•90% [
     <xref ref-type="bibr" rid="CR14">14</xref>]
    </td>
   </tr>
   <tr>
    <td rowspan="2">Hepatitis A virus (HAV)</td>
    <td>•Condoms</td>
    <td>•Not known</td>
   </tr>
   <tr>
    <td>•Hepatitis A vaccination</td>
    <td>•93% [
     <xref ref-type="bibr" rid="CR15">15</xref>]
    </td>
   </tr>
   <tr>
    <td rowspan="2">Hepatitis B virus (HBV)</td>
    <td>•Condoms</td>
    <td>•Not known</td>
   </tr>
   <tr>
    <td>•Hepatitis B vaccination</td>
    <td>• &gt; 90% [
     <xref ref-type="bibr" rid="CR16">16</xref>]
    </td>
   </tr>
   <tr>
    <td rowspan="2">Herpes virus (HSV 1 &amp; 2)</td>
    <td>•Condoms</td>
    <td>•24% [
     <xref ref-type="bibr" rid="CR17">17</xref>]
    </td>
   </tr>
   <tr>
    <td>•Prophylactic treatment</td>
    <td>•48% [
     <xref ref-type="bibr" rid="CR17">17</xref>]
    </td>
   </tr>
   <tr>
    <td rowspan="4">Human Immunodeficiency Virus (HIV)</td>
    <td>•Condoms</td>
    <td>•10% [
     <xref ref-type="bibr" rid="CR18">18</xref>]
    </td>
   </tr>
   <tr>
    <td>•Circumcision</td>
    <td>•57% [
     <xref ref-type="bibr" rid="CR13">13</xref>]
    </td>
   </tr>
   <tr>
    <td>•Treatment as prevention</td>
    <td>•93% [
     <xref ref-type="bibr" rid="CR19">19</xref>]
    </td>
   </tr>
   <tr>
    <td>•Preexposure prophylaxis (PrEP)</td>
    <td>• &gt; 90% [
     <xref ref-type="bibr" rid="CR20">20</xref>]
    </td>
   </tr>
  </tbody>
 </table>
 <table-wrap-foot>
  <p>*Abstinence has not been included since it is a rare component of the CSW client relationship</p>
 </table-wrap-foot>
</table-wrap>
